Status:

COMPLETED

Tegafur-Uracil and Leucovorin or S-1 in Treating Patients With Stage III Colon Cancer That Has Been Completely Removed by Surgery

Lead Sponsor:

Translational Research Center for Medical Innovation, Kobe, Hyogo, Japan

Conditions:

Colorectal Cancer

Eligibility:

All Genders

20-80 years

Phase:

PHASE3

Brief Summary

RATIONALE: Drugs used in chemotherapy, such as tegafur-uracil, leucovorin, and S-1, work in different ways to stop the growth of tumor cells, either by killing the cells or by stopping them from divid...

Detailed Description

OBJECTIVES: * Compare the disease-free survival of patients with stage III colon cancer treated with S-1 or tegafur-uracil and leucovorin after curative surgery . OUTLINE: Patients are randomized to...

Eligibility Criteria

Inclusion

  • DISEASE CHARACTERISTICS:
  • Histologically confirmed adenocarcinoma of colon
  • Stage III (T1-4, N1-3, M0) disease
  • Has undergone surgical resection of the tumor within the past 8 weeks
  • PATIENT CHARACTERISTICS:
  • ECOG performance status 0-1
  • Able to take medications orally
  • WBC ≥ 3,500/mm³ and \< 12,000/mm³
  • ANC ≥ 1,500/mm³
  • Platelet count ≥ 100,000/mm³
  • Hemoglobin ≥ 9.0 g/dL
  • Total bilirubin ≤ 2.0 mg/dL
  • AST/ALT ≤ 100 IU/L
  • Creatinine ≤ 1.2 mg/dL
  • No other active malignancies
  • Must have none of the following comorbidities:
  • Severe postoperative complications
  • Uncontrollable diabetes mellitus
  • Uncontrollable hypertension
  • Myocardial infraction within 6 months
  • Unstable angina pectoris
  • Hepatocirrhosis
  • Interstitial pneumonia, pulmonary fibrosis, or severe emphysema
  • PRIOR CONCURRENT THERAPY:
  • No prior chemotherapy or radiotherapy for colon cancer
  • No concurrent radiotherapy
  • No concurrent biological response modifiers

Exclusion

    Key Trial Info

    Start Date :

    April 1 2008

    Trial Type :

    INTERVENTIONAL

    Allocation :

    ACTUAL

    End Date :

    July 1 2015

    Estimated Enrollment :

    1535 Patients enrolled

    Trial Details

    Trial ID

    NCT00660894

    Start Date

    April 1 2008

    End Date

    July 1 2015

    Last Update

    August 3 2016

    Active Locations (1)

    Enter a location and click search to find clinical trials sorted by distance.

    Page 1 of 1 (1 locations)

    1

    Tokyo Medical and Dental University

    Tokyo, Tokyo, Japan, 113-8519